Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

informed
November 27, 2024
9:22 pm

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Active membership Required to Read Full Story

Star

March 27, 2025

Top Conservative strategist says Poilievre needs to urgently pivot or he will lose

One of the country’s top Conservative strategists who just helped…

‘Christmas creep’ is here as the retail season starts early. But is it about consumerism or comfort?

IfÂ it seems like the Christmas shoppingÂ season starts earlier…

Canadian shot putter Greg Stewart repeats as Paralympic champion in Paris | CBC Sports

Canada’s Greg Stewart successfully defended his Paralympic title in the…

This is an example headline 2

This is an example headline

Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

Active membership Required to Read Full Story

Related Posts

Top Conservative strategist says Poilievre needs to urgently pivot or he will lose

Read More >

‘Christmas creep’ is here as the retail season starts early. But is it about consumerism or comfort?

Read More >

Canadian shot putter Greg Stewart repeats as Paralympic champion in Paris | CBC Sports

Read More >

Subscribe Our Newsletter

Quick Links

Account